Michael Mensinger
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Mr. Michael R.
Mensinger is a Chief Product Officer at Beta Bionics, Inc. Mr. Mensinger was previously employed as a Chief Technology Officer by Companion Medical, Inc. and an Engineering Manager by DexCom, Inc. He received his undergraduate degree from the University of Delaware.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BETA BIONICS, INC. 0.41% | 02.06.2026 | 184’415 ( 0.41% ) | 2 Mio $ | 31.05.2026 |
BETA BIONICS, INC. -.--% | 29.01.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BETA BIONICS, INC. | Corporate Officer/Principal | 01.08.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2023 |
| DEXCOM, INC. | Corporate Officer/Principal | 01.04.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Companion Medical, Inc.
Companion Medical, Inc. Medical SpecialtiesHealth Technology Manufactures insulin injector pens for diabetes management | Health Technology |
DexCom, Inc.
DexCom, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes continuous glucose monitoring systems for management of diabetes & metabolic health by patients, caregivers and clinicians | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beta Bionics, Inc.
Beta Bionics, Inc. Medical SpecialtiesHealth Technology Designs, develops, manufactures and markets medical devices for diabetes disease | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen